0.80
price down icon0.01%   -0.000100
after-market Handel nachbörslich: .80
loading
Schlusskurs vom Vortag:
$0.8001
Offen:
$0.799
24-Stunden-Volumen:
420.77K
Relative Volume:
0.48
Marktkapitalisierung:
$15.66M
Einnahmen:
$1.89M
Nettoeinkommen (Verlust:
$-17.92M
KGV:
-0.1196
EPS:
-6.69
Netto-Cashflow:
$-15.62M
1W Leistung:
-1.11%
1M Leistung:
+1.57%
6M Leistung:
-44.64%
1J Leistung:
-58.76%
1-Tages-Spanne:
Value
$0.79
$0.8299
1-Wochen-Bereich:
Value
$0.775
$0.99
52-Wochen-Spanne:
Value
$0.633
$2.4843

Longeveron Inc Stock (LGVN) Company Profile

Name
Firmenname
Longeveron Inc
Name
Telefon
305-302-7158
Name
Adresse
1951 NW 7TH AVENUE, MIAMI
Name
Mitarbeiter
25
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
LGVN's Discussions on Twitter

Vergleichen Sie LGVN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LGVN
Longeveron Inc
0.80 16.85M 1.89M -17.92M -15.62M -6.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Longeveron Inc Stock (LGVN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-06 Eingeleitet ROTH MKM Buy

Longeveron Inc Aktie (LGVN) Neueste Nachrichten

pulisher
05:05 AM

Tick level data insight on Longeveron Inc. volatilityPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com

05:05 AM
pulisher
04:49 AM

Using RSI to spot recovery in Longeveron Inc.Weekly Earnings Recap & Community Verified Trade Signals - newser.com

04:49 AM
pulisher
02:42 AM

Should you wait for a breakout in Longeveron Inc.2025 Earnings Impact & Reliable Breakout Stock Forecasts - newser.com

02:42 AM
pulisher
Oct 13, 2025

Is Longeveron Inc. building a consolidation basePortfolio Performance Report & High Return Trade Guides - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Longeveron Inc. stock continue dividend increases2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Longeveron Inc. stock outlook for YEARTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Is Longeveron Inc. stock overvalued by current metricsTrade Exit Report & Technical Entry and Exit Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Signal strength of Longeveron Inc. stock in tech scannersMarket Movement Recap & Detailed Earnings Play Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Longeveron Inc. stock outperform tech sector in 2025GDP Growth & Weekly Market Pulse Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

What high frequency data says about Longeveron Inc.Trade Analysis Summary & Daily Profit Focused Stock Screening - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Real time breakdown of Longeveron Inc. stock performanceLayoff News & AI Based Buy and Sell Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews

Oct 09, 2025
pulisher
Oct 08, 2025

What drives Longeveron Inc stock priceCovered Call Writing & Outstanding Portfolio Growth - earlytimes.in

Oct 08, 2025
pulisher
Oct 06, 2025

Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - The Manila Times

Oct 06, 2025
pulisher
Oct 06, 2025

What earnings revisions data tells us about Longeveron Inc.2025 Investor Takeaways & Stock Portfolio Risk Management - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Forecasting Longeveron Inc. price range with options dataJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Custom strategy builders for tracking Longeveron Inc.July 2025 Earnings & Weekly Top Gainers Trade List - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using portfolio simulators with Longeveron Inc. includedBond Market & Safe Capital Growth Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 02:00:03 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Will Longeveron Inc. bounce back from current supportJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 03:24:01 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Leading vs lagging indicators on Longeveron Inc. performanceMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Longeveron Appoints Dr. George Paletta to Board - The Globe and Mail

Oct 02, 2025
pulisher
Oct 02, 2025

Longeveron adds Cardinals team doctor to board of directors By Investing.com - Investing.com Nigeria

Oct 02, 2025
pulisher
Oct 01, 2025

Longeveron adds Cardinals team doctor to board of directors - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors - The Manila Times

Oct 01, 2025
pulisher
Oct 01, 2025

George Paletta, Jr., MD, MBA, Internationally Acclaimed - GlobeNewswire

Oct 01, 2025
pulisher
Oct 01, 2025

$1B Healthcare Deal Maker and St. Louis Cardinals Team Doctor Joins Longeveron's Board for Stem Cell Push - Stock Titan

Oct 01, 2025
pulisher
Oct 01, 2025

Longeveron (NASDAQ:LGVN) Stock Price Down 2.6% – Here’s Why - Defense World

Oct 01, 2025

Finanzdaten der Longeveron Inc-Aktie (LGVN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Longeveron Inc-Aktie (LGVN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Soffer Rock
Director
May 29 '25
Sale
1.30
10,000
13,000
220,034
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):